TREML2: Target/Biomarker Introduction, products summarized (antibody/ADC/bispecific/antigen/ORF vector/VLP) and disease/indication/condition/MOA for drug discovery and IVD

It’s the GeneMedi’s summary page for Target/Biomarker Introduction of TREML2. The page also collects GeneMedi’s different modalities and formats products for TREML2 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi’s target-insight database-GM ITD database, the TREML2 target is also connected to human indications/diseases/conditions/MOA.

Target sublocation: Transmembrane Protein.

TREML2 is located in a gene cluster on chromosome 6 with the single Ig variable (IgV) domain activating receptors TREM1 (MIM 605085) and TREM2 (MIM 605086), but it has distinct structural and functional properties (Allcock et al., 2003 [PubMed 12645956]).[supplied by OMIM, Mar 2008]

Target ID
GM-MP1873

Target Name
TREML2

Gene ID
79865

Gene Official Name
TREML2

Gene Alias
C6orf76, TLT-2, TLT2, dJ238O23.1

Protein Sub-location
Transmembrane Protein

Category

Anti-TRML2/ TREML2/ C6orf76 antibody for FACS & in-vivo assay| GMab

Pre-made anti-TREML2 benchmark inhibitory monoclonal antibody(mab, blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-TREML2 mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Filters Sort results
Reset Apply
Cat No.
Antibody Name
Format
Classified by tag
Order
GM-Tg-hg-MP1873-Ab
Anti-TREML2 monoclonal antibody
mab
FACS/Biofunctional Antibody